| Grant Thomas Young, APRN-CNP | |
|
3200 Quail Springs Pkwy Ste 200, Oklahoma City, OK 73134-2699 | |
| (405) 241-3539 | |
| (405) 241-0998 |
| Full Name | Grant Thomas Young |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Location | 3200 Quail Springs Pkwy Ste 200, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629791777 | NPI | - | NPPES |
| 210343 | Other | OK | OKLAHOMA STATE BOARD OF NURSING |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SG0600X | Clinical Nurse Specialist - Gerontology | 210343 (Oklahoma) | Secondary |
| 363L00000X | Nurse Practitioner | 210343 (Oklahoma) | Primary |
| Entity Name | Cardiovascular Health Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215324553 PECOS PAC ID: 5597070326 Enrollment ID: O20150821014510 |
News Archive
A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy.
Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.
Interpace Diagnostics announced today that Laboratory Corporation of America Holdings, the world's leading health care diagnostics company, will begin offering Interpace's new ThyraMir microRNA classifier test.
The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Grant Thomas Young, APRN-CNP Po Box 258857, Oklahoma City, OK 73125-8857 Ph: (405) 241-3539 | Grant Thomas Young, APRN-CNP 3200 Quail Springs Pkwy Ste 200, Oklahoma City, OK 73134-2699 Ph: (405) 241-3539 |
News Archive
A new type of breast cancer drug developed by researchers at the University of Illinois Chicago can help halt progression of disease and is not toxic, according to phase 1 clinical trials. The drug is specifically designed for women whose cancer has stopped responding to hormone therapy.
Tomorrow (Friday, June 11), Family Research Council Senior Fellow Peter Sprigg will testify before the Advisory Committee on Blood Safety and Availability (ACBSA) of the Department of Health and Human Services.
Interpace Diagnostics announced today that Laboratory Corporation of America Holdings, the world's leading health care diagnostics company, will begin offering Interpace's new ThyraMir microRNA classifier test.
The Lupus Research Institute (LRI) today named 12 new grant recipients for 2009. The awards, totaling $3.6 million, recognize innovative work across a broad spectrum of lupus research. All were selected for their creativity, novelty, and potential to drive scientific discovery to ultimately prevent, treat, and cure the complex disease of systemic lupus.
Trevena, Inc., a clinical stage pharmaceutical company involved in the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced the pricing of its initial public offering of 9,250,000 shares of common stock at a price of $7.00 per share.
› Verified 4 days ago
Ann R Benson, BSN, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1000 Ne 10th St, Oklahoma City, OK 73117 Phone: 405-271-4476 Fax: 405-271-9202 | |
Mrs. Judy Kay Kellogg, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1025 Straka Ter, Oklahoma City, OK 73139 Phone: 405-632-6688 Fax: 405-604-0708 | |
Mrs. Darbi Lynne Williams, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4050 W Memorial Rd, Oklahoma City, OK 73120 Phone: 405-608-3800 Fax: 405-608-3838 | |
Tammy Ann Harrelson, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14000 N Portland Ave, Suite 201, Oklahoma City, OK 73134 Phone: 405-606-2727 Fax: 405-606-7040 | |
Liji Seilas, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1901 Springlake Dr, Oklahoma City, OK 73111 Phone: 405-521-8486 Fax: 405-521-8496 | |
Hilary Lauren Knippers, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3110sw89th St 200d, Oklahoma City, OK 73159 Phone: 405-680-5633 Fax: 405-799-7400 | |
Mrs. Rachel Leigh Cross, APRN, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Childrens Ave, Suite 10000, Oklahoma City, OK 73104 Phone: 405-271-4412 |